Non-responders to bevacizumab (Avastin) therapy of choroidal neovascular lesions.
N
N
Nigam
J
J
Hedaya
W R
WR
Freeman
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000503:physiopathology; D003627:Data Interpretation, Statistical; D006801:Humans; D017211:Treatment Failure; D014792:Visual Acuity
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab